Fusanori Yotsumoto

发表

New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting molecule.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2007, Anticancer research.

Heparin‐binding epidermal growth factor‐like growth factor as a novel targeting molecule for cancer therapy

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2006, Cancer science.

Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2005, Gynecologic oncology.

Apoptosis as a possible candidate mechanism for removal of tamoxifen-related endometrial cells with KRAS mutations.

S. Miyamoto, Fusanori Yotsumoto, T. Yoshizato, 2010, Anticancer research.

NG2 Proteoglycan‐Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression

Fusanori Yotsumoto, W. You, P. Cejudo-Martı́n, 2016, Microcirculation.

Peri-operative complications of Total laparoscopic hysterectomy for benign gynecological diseases in Fukuoka university

S. Miyamoto, Fusanori Yotsumoto, Y. Kanamori, 2021, JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY.

Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancer.

S. Miyamoto, Fusanori Yotsumoto, E. Mekada, 2012, American journal of translational research.

S. Miyamoto, Fusanori Yotsumoto, T. Yoshizato, 2016, Journal of Medical Ultrasonics.

A partial supernumerary umbilical vein: a case report

S. Miyamoto, Fusanori Yotsumoto, M. Hamasaki, 2019, Journal of Medical Case Reports.

Invasive potency related to RCAS1 expression in uterine cervical cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2005, Gynecologic oncology.

Separation efficiency of a microfluidic sperm sorter to minimize sperm DNA damage.

S. Miyamoto, Fusanori Yotsumoto, H. Itoh, 2016, Fertility and sterility.

Clinical significance of RCAS1 as a biomarker of uterine cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2006, Gynecologic oncology.

HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFRT790M.

S. Miyamoto, Fusanori Yotsumoto, S. Manabe, 2017, Anticancer research.

HB-EGF inhibition in combination with various anticancer agents enhances its antitumor effects in gastric cancer.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2010, Anticancer research.

Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2011, Anticancer research.

Clinical significance of RCAS1 as a biomarker of ovarian cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2007, Oncology Report.

Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.

S. Miyamoto, Fusanori Yotsumoto, C. Ishikawa, 2012, Cancer letters.

Antitumour Effects of Intravenous Administration of BK-UM, a Novel Inhibitor of HB-EGF, in Ovarian Cancer Therapy.

S. Miyamoto, Fusanori Yotsumoto, S. Manabe, 2017, Anticancer research.

Validity of HB-EGF as Target for Human Neuroblastoma Therapy.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2015, Anticancer research.

Amphiregulin regulates the production of human chorionic gonadotropin in trophoblasts.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2009, Life sciences.

Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2017, Anticancer research.

Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer.

S. Miyamoto, Fusanori Yotsumoto, T. Kawarabayashi, 2009, Fertility and sterility.

Adipose tissue-derived regenerative cells improve implantation of fertilized eggs in thin endometrium.

S. Miyamoto, Fusanori Yotsumoto, S. Sobajima, 2020, Regenerative medicine.

Warburg effect regulated by amphiregulin in the development of colorectal cancer

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2015, Cancer medicine.

Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome

M. Hattori, S. Miyamoto, Fusanori Yotsumoto, 2017, Scientific Reports.

NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization

Kenji Sakimura, K. Sakimura, Fusanori Yotsumoto, 2015, Oncoimmunology.

Synergistic anti‐tumor effect of paclitaxel with CRM197, an inhibitor of HB‐EGF, in ovarian cancer

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2009, International journal of cancer.

Usefulness of LigaSureTM in laparoscopic salpingectomy for tubal pregnancy

S. Miyamoto, Fusanori Yotsumoto, Tomohiro Ito, 2022, JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY.

Efficacy of ligand-based targeting for the EGF system in cancer.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2009, Anticancer research.

Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2011, Anticancer research.

HB‐EGF orchestrates the complex signals involved in triple‐negative and trastuzumab‐resistant breast cancer

E. Tokunaga, E. Oki, Y. Maehara, 2010, International Journal of Cancer.

A possible clinical adaptation of CRM197 in combination with conventional chemotherapeutic agents for ovarian cancer.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2011, Anticancer research.

Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2011, Current opinion in obstetrics & gynecology.

Emerging strategies for ErbB ligand-based targeted therapy for cancer.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2010, Anticancer research.

NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function

Fusanori Yotsumoto, W. You, R. Adams, 2013, Angiogenesis.

Vaginal microbiome as a tool for prediction of chorioamnionitis in preterm labor: a pilot study

M. Hattori, S. Miyamoto, Fusanori Yotsumoto, 2021, Scientific Reports.

Potential for molecularly targeted therapy against epidermal growth factor receptor ligands.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2009, Anticancer research.

Biological response modifiers used in cancer biotherapy.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2012, Anticancer research.

Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2008, Advances in experimental medicine and biology.

Heparin-binding epidermal growth factor–like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2008, Molecular Cancer Therapeutics.

Clinical significance of amphiregulin and epidermal growth factor in colostrum

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2012, Archives of Gynecology and Obstetrics.

Validation of HB-EGF and amphiregulin as targets for human cancer therapy.

Satoshi O. Suzuki, E. Oki, S. Miyamoto, 2008, Biochemical and biophysical research communications.

MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2017, Cancer science.

Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis

S. Miyamoto, Fusanori Yotsumoto, K. Nabeshima, 2021, Scientific Reports.

Cumulative Summation Analysis of Learning Curve for Robotic-assisted Hysterectomy in Patients With Gynecologic Tumors

S. Miyamoto, Fusanori Yotsumoto, S. Yasunaga, 2022, AntiCancer Research.

NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function

K. Sakimura, Fusanori Yotsumoto, W. You, 2013, Angiogenesis.

Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome

M. Hattori, S. Miyamoto, Fusanori Yotsumoto, 2017, Scientific Reports.

Abstract 4524: Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of a novel Bcl-2 family inhibitor, ABT-737

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2010 .

MicroRNAs miR-4535 and miR-1915-5p in amniotic fluid as predictive biomarkers for chorioamnionitis

Tetsuya Hayashi, S. Miyamoto, Fusanori Yotsumoto, 2021, Future science OA.

Clinical Features of Recurrence in Patients Without Residual Tumour in Endometrial Cancer

S. Miyamoto, Fusanori Yotsumoto, Y. Kanamori, 2019, AntiCancer Research.

Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2012, Anticancer research.

Nuclear Factor Kappa B (NF-κB) in Inflammation

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2012 .

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study

S. Miyamoto, Fusanori Yotsumoto, T. Yoshizato, 2017, BMC Cancer.

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma

S. Takada, S. Miyamoto, Fusanori Yotsumoto, 2014, Cancer medicine.

Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer

E. Tokunaga, E. Oki, Y. Maehara, 2013, Molecular Cancer Research.

A Novel Anti-Human HB-EGF Monoclonal Antibody with Multiple Antitumor Mechanisms against Ovarian Cancer Cells

K. Shitara, S. Miyamoto, H. Yagi, 2011, Clinical Cancer Research.

Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2010, Cancer science.

The combination of maternal blood and amniotic fluid biomarkers improves the predictive accuracy of histologic chorioamnionitis.

S. Miyamoto, Fusanori Yotsumoto, H. Arima, 2019, Placenta.

Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2018, AntiCancer Research.

Proteolytic activation of heparin‐binding EGF‐like growth factor by membrane‐type matrix metalloproteinase‐1 in ovarian carcinoma cells

S. Miyamoto, Fusanori Yotsumoto, E. Mekada, 2011, Cancer science.

HB-EGF involved in peritoneal implantation of ovarian cancer

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2006 .

Safety and Anti-tumor Effects of Docetaxel Plus Cisplatin in Intermediate- and High-risk Endometrial Cancer.

S. Miyamoto, Fusanori Yotsumoto, Yoko Takahashi, 2016, Anticancer research.

HB‐EGF orchestrates the complex signals involved in triple‐negative and trastuzumab‐resistant breast cancer

E. Tokunaga, E. Oki, Y. Maehara, 2010, International journal of cancer.

S. Miyamoto, Fusanori Yotsumoto, T. Kawarabayashi, 2009, Fertility and sterility.

Safety and Potential Effect of Intrauterine Infusion of Autologous Adipose Tissue-Derived Regenerative Cells in Patients With Implantation Failure: A Pilot Study

Fusanori Yotsumoto, S. Yasunaga, S. Kodama, 2024, Cureus.